| P2093 | author name string | Ayman Akil | |
| | Brid Devlin | |
| | Lisa Cencia Rohan | |
| | Marilyn Cost | |
| P2860 | cites work | Microbicides: topical prevention against HIV | Q26999403 |
| | An antiretroviral/zinc combination gel provides 24 hours of complete protection against vaginal SHIV infection in macaques | Q27438093 |
| | Reverse transcriptase inhibitors as microbicides | Q30412039 |
| | Formulation, pharmacokinetics and pharmacodynamics of topical microbicides | Q30412592 |
| | A vaginal fluid simulant | Q33653706 |
| | Combination of candidate microbicides cellulose acetate 1,2-benzenedicarboxylate and UC781 has synergistic and complementary effects against human immunodeficiency virus type 1 infection | Q33770052 |
| | Dawn of non-nucleoside inhibitor-based anti-HIV microbicides | Q34487295 |
| | In vitro evaluation of nonnucleoside reverse transcriptase inhibitors UC-781 and TMC120-R147681 as human immunodeficiency virus microbicides | Q35006752 |
| | In vitro resistance profile of the candidate HIV-1 microbicide drug dapivirine | Q35689311 |
| | Development and Characterization of a Vaginal Film Containing Dapivirine, a Non- nucleoside Reverse Transcriptase Inhibitor (NNRTI), for prevention of HIV-1 sexual transmission | Q36033871 |
| | Safety and efficacy of tenofovir/IQP-0528 combination gels - a dual compartment microbicide for HIV-1 prevention | Q36409617 |
| | Inhibition of human immunodeficiency virus type 1 infection by the candidate microbicide dapivirine, a nonnucleoside reverse transcriptase inhibitor | Q37072072 |
| | Topical microbicides to prevent HIV: clinical drug development challenges | Q37324508 |
| | Complete protection from repeated vaginal simian-human immunodeficiency virus exposures in macaques by a topical gel containing tenofovir alone or with emtricitabine | Q37365377 |
| | Microbicide delivery: formulation technologies and strategies. | Q37447846 |
| | The future of HIV microbicides: challenges and opportunities. | Q37448790 |
| | Specific microbicides in the prevention of HIV infection | Q37932048 |
| | Future strategies in microbicide development | Q37992384 |
| | In vitro and ex vivo evaluation of polymeric nanoparticles for vaginal and rectal delivery of the anti-HIV drug dapivirine | Q39143650 |
| | Synergistic inhibition of HIV-1 infection by combinations of soluble polyanions with other potential microbicides | Q40149698 |
| | Synergy against drug-resistant HIV-1 with the microbicide antiretrovirals, dapivirine and tenofovir, in combination | Q42733122 |
| | Pharmacokinetics of 2 dapivirine vaginal microbicide gels and their safety vs. Hydroxyethyl cellulose-based universal placebo gel. | Q43007169 |
| | Segmented polyurethane intravaginal rings for the sustained combined delivery of antiretroviral agents dapivirine and tenofovir | Q43230603 |
| | A silicone elastomer vaginal ring for HIV prevention containing two microbicides with different mechanisms of action | Q43611191 |
| | Safety, tolerability, and systemic absorption of dapivirine vaginal microbicide gel in healthy, HIV-negative women | Q43809456 |
| | Pharmacokinetic Assessment of Dapivirine Vaginal Microbicide Gel in Healthy, HIV-Negative Women | Q57847699 |
| | Safety and Availability of Dapivirine (TMC120) Delivered from an Intravaginal Ring | Q57847719 |
| | In vitro profiling of the vaginal permeation potential of anti-HIV microbicides and the influence of formulation excipients | Q59285485 |
| | Distribution of lymphocytes and adhesion molecules in human cervix and vagina | Q62638937 |
| | Carrageenan/MIV-150 (PC-815), a combination microbicide | Q80149044 |
| | Mucosal safety of PHI-443 and stampidine as a combination microbicide to prevent genital transmission of HIV-1 | Q80324830 |
| | Design of tenofovir-UC781 combination microbicide vaginal gels | Q83498741 |
| | Safety and pharmacokinetics of dapivirine delivery from matrix and reservoir intravaginal rings to HIV-negative women | Q84273601 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | tenofovir | Q155954 |
| P304 | page(s) | 1533-1541 | |
| P577 | publication date | 2014-04-14 | |
| P1433 | published in | Molecular Pharmaceutics | Q3011140 |
| P1476 | title | Increased Dapivirine tissue accumulation through vaginal film codelivery of dapivirine and Tenofovir | |
| P478 | volume | 11 | |